butabarbital


Also found in: Wikipedia.

butabarbital

 [bu″tah-bahr´bĭ-tal]
a short- to intermediate-acting barbiturate, used preoperatively as the base or sodium salt as a sedative and hypnotic aid to anesthesia. Administered orally.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

butabarbital

A fast-acting sedative/hypnotic of intermediate duration of action.
 
Adverse effects
Drowsiness, insomnia, nightmares, headaches, dizziness, depression, excitability, restlessness, nausea, vomiting, constipation, dyspnoea.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

butabarbital

Pyridium® Pharmacology A sedative/hypnotic of intermediate duration of action
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
Mentioned in ?
References in periodicals archive ?
The label change affects drugs including Zolpidem, marketed as Ambien/Ambien CR by Sanofi-Aventis; butabarbital, marketed as Butisol Sodium by Medpointe Pharmaceuticals HLC; flurazepam, marketed as Dalmane by Valeant Pharmaceuticals; quazepam, marketed as Doral by Questcor Pharmaceuticals; triazolam, marketed as Halcion by Pharmacia & Upjohn Inc.; eszopiclone, marketed as Lunesta by Sepracor Inc.; estazolam, marketed as Prosom by Abbott; temazepam, marketed as Restoril by Tyco Healthcare Group; ramelteon, marketed as Rozerem by Takeda Pharmaceutical Inc.; secobarbital, marketed as Seconal by Ranbaxy Pharmaceuticals Inc.; and zaleplon, marketed as Sonata by King Pharmaceuticals Inc.
Sleep drug labels to address adverse reactions
The label change affects drugs including Zolpidem, marketed as Ambien/Ambien CR by Sanofi-Aventis; butabarbital, marketed as Butisol Sodium by Medpointe Pharmaceuticals HLC; flurazepam, marketed as Dalmane by Valeant Pharmaceuticals; quazepam, marketed as Doral by Questcor Pharmaceuticals; triazolam, marketed as Halcion by Pharmacia & Up-john Inc.; eszopiclone, marketed as Lunesta by Sepracor Inc.; estazolam, marketed as Prosom by Abbott; temazepam, marketed as Restoril by Tyco Healthcare Group; ramelteon, marketed as Rozerem by Takeda Pharmaceutical Inc.; secobarbital, marketed as Seconal by Ranbaxy Pharmaceuticals Inc.; and zaleplon, marketed as Sonata by King Pharmaceuticals Inc.
Sleep drug labels to address adverse effects
It was later discovered that his bodycontained butabarbital, codeine, morphine, pentobarbital, Placidyl, Quaalude, Valium and Valmid.
God's Rockers
The autopsy - kept hidden for years - recorded that the 14 drugs in Elvis's body that day included butabarbital, codeine, morphine, pentobarbital, Placidyl, Quaalude, valium and Valmid.
Elvis Review: INTERVIEW: JOE ESPOSITO: THE KING AND I; TRIBUTE TO A ROCK 'N' ROLL LEGEND ON THE 25TH ANNIVERSARY OF HIS DEATH

Medical browser ?
Full browser ?